We develop complex dosage forms enabling early market entry generic drugs and innovative supergeneric products. We deal with licensing-out to leading Pharma partners worldwide for market access.
Via Figino 6, 6917 Barbengo, Switzerland
Hengrui Europe Biosciences is a biotech start-up based in Zurich, Switzerland, established in 2021. We are a subsidiary of Jiangsu Hengrui Pharmaceuticals Co., Ltd. and are building a new research center with a differentiated technology platform to support innovative antibody discovery research.
Praed Pharmaceuticals is biopharmaceutical company founded by industry experts. Our mission is to deliver a next generation treatment for Crohn’s disease. We are developing a promising oral compound, cadazolid, for the treatment of Crohn’s disease.